Recent

% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • kyjellie kyjellie Dec 27, 2012 1:45 PM Flag

    #$%$;

    Batzem,

    Answer the man. This one is on you to call him stupid, like you called Deb. Buysell wait for Batzem to respond too your question. In the past we have had a huge disagreement on this subject and Batzem spend 10 days and reserach it up and down and came back with exactly what Deb posted.

    Answer the man Batzem.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Buy Sell

      You are correct "if it were a combination" pill it could be patented but would not help Dacogen it would help the developer of the vaccine. But since its not a pill it cant be panteted The treatment would not be patentable only the vaccine.

      KY your friend Deb and I did not reach the same conclusion. She insisted that sInce so many studies were being done by J&J and Eisai that Dacogen patent would be extended or why else would they do the studies, I said the patent could not be extended( past the pediatric extension.if they get it . I was right she was wrong . Ive been trying to keep the peace but you do love conflict dont you.

      • 1 Reply to batzem
      • Batzem,

        It just seem like a good time to raise this issue. I had hoped that someone with some knowledge of the subject would intervien and explain this better. You lost me on the pill part immediately.

        What motivates the drug manufactures to run additional trials if they gain no protections. The example Deb used was Viagra. The drug originally was in trials for hypertension. It was approved for this indication. During the trials, the ED became apparent. So they ran additional trials for it. Getting approval and protection. Right now generics can go after hypertension, but not ED.

        I believe in MDS they lose protection. However if they spend the funds to combine this drug in a new indication, I believe they get rewarded. As you explain it, they get nothing in the USA. That cannot be right. You have never produce anything but your opinion. On top of that you insulted Deb for asking a question that you couldn't explain, even after a week.

        Why did they go after aml in the USA? If the board had approved aml use in the USA, is your point that they would only have had 12 months of protection? BTW batzem, I have left you out of 99.9% of my posts, since you asked for a truce. I had hoped here to welcome this debate, in hopes that someone produce quantative info on this matter. I believe aml,cml,hiv,solid cancers,transfusion priming are all new indications.

        Do you think the generic companies are going to spend one dime on other indications? We all waited for you to produce something, you didn#$%$ a common sense issue. They went after a pill form of dac and vidaza in MDS, why? Did they want to be nice guys and help the generic boys with a less expensive drug to make. You need to wrap up all the ends.

        Sentiment: Strong Buy

 
ASTX
8.4950.000(0.00%)Oct 10 4:00 PMEDT